Related Experiment Video

Updated: Jul 8, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
08:34

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat

Published on: November 18, 2018

Surgical removal of a left ventricular thrombus associated with cardiac sarcoidosis

Shinji Kanemitsu1, Yoichiro Miyake, Manabu Okabe

  • 1Division of Cardiovascular Surgery, Kochi Health Sciences Center, Kochi, Japan. skanemitsu70@yahoo.co.jp

Interactive Cardiovascular and Thoracic Surgery
|January 23, 2008
PubMed

Insights

This study details the successful surgical removal of a rare left ventricular thrombus in a patient with cardiac sarcoidosis. The case highlights surgical intervention for heart failure caused by this uncommon condition.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Immunology

Background:

  • Cardiac sarcoidosis is an inflammatory condition that can lead to heart failure.
  • Left ventricular thrombus formation is a known complication of heart failure.
  • Surgical management of left ventricular thrombus in cardiac sarcoidosis is exceptionally rare.

Observation:

  • A 31-year-old male presented with heart failure secondary to cardiac sarcoidosis.
  • Echocardiography revealed diffuse hypokinesis and a mobile, ball-like left ventricular thrombus.
  • CT and MRI demonstrated findings suggestive of cardiac sarcoidosis and cerebral infarctions.

Findings:

  • Surgical excision of the left ventricular thrombus was successfully performed.
  • Pathological examination confirmed non-caseating granulomas, indicative of cardiac sarcoidosis.
  • The patient received postoperative treatment with prednisolone for cardiac sarcoidosis.

Implications:

  • This case demonstrates the feasibility of surgical intervention for left ventricular thrombus in cardiac sarcoidosis.
  • Early diagnosis and multidisciplinary management are crucial for patients with cardiac sarcoidosis.
  • Further research may explore optimal treatment strategies for this rare presentation.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...